Exhibited at Japan Healthcare Venture Summit 2020 (JHVS2020)

We will exhibit at JHVS2020!
See you at Pacifico Yokohama in Japan from October 14th to 16th, 2020.

JHVS2020

We will exhibit at JHVS2020 as the same in 2018 and 2019.
At exhibition booths, business partnering programs, exhibitor presentations, etc.
We look forward to seeing you all.

Exhibitor presentation

We will pitch our business(by Fumikazu Wanibuchi, Director of Clinical Development Department).

Date and time:	Friday, October 16th, 14:30-14:40
Venue	Pacifico Yokohama Exhibition Hall Presentation Stage B
Title	“Brain Access (TM) to CNS Therapies: Targeted Drug Delivery Technology”

Please see below for the detailed schedule of the entire project.

Date and time:	Friday, October 16th, 13:00-15:00
Venue	Pacifico Yokohama Exhibition Hall Presentation Stage B

[Reference] Partnering program

You can use various services for business negotiations and networking, from entry to matching members (paid), introduction of seeds, technical tie-ups, and corporate alliances
It is also possible to link with WEB conference tools (online meetings). In addition, the time slot has been expanded compared to the past to solve the jet lag problem with Europe and the United States (JST 6: 00-22: 00).
https://www.ics-expo.jp/biojapan/en/partnering.html

[Reference] Outline of Japan Healthcare Venture Summit Event

Date and time	Wednesday, October 14th to Friday, October 16th
Venue	Pacifico Yokohama (sponsored by Ministry of Health, Labor and Welfare))

Event overview

https://www.ics-expo.jp/biojapan/en/

[Reference] Event organizer seminar

Event name:Evolution of drug discovery modality

Date and time	Friday, October 16th, 15: 30-17: 00
Location	F205-206 Venue ※Pre-registration is required（https://www.ics-expo.jp/biojapan/en/visitor.html）。
Coordinator	Hitoshi Kuboba (Adviser, Chugai Pharmaceutical Co., Ltd.) AI technology and drug discovery modality-a new era of seamless medical care- Norikazu Eiki (Aiki Consulting) Takeshi Wada (Tokyo University of Science) SmeWG’s interim activity report on gene cell therapy (provisional) Masanobu Kimura (Takara Bio)

Date and time

Friday, October 16th, 15: 30-17: 00

Location

F205-206 Venue
※Pre-registration is required（https://www.ics-expo.jp/biojapan/en/visitor.html）。

Coordinator

Hitoshi Kuboba (Adviser, Chugai Pharmaceutical Co., Ltd.)

AI technology and drug discovery modality-a new era of seamless medical care-
Norikazu Eiki (Aiki Consulting)

Takeshi Wada (Tokyo University of Science)

SmeWG’s interim activity report on gene cell therapy (provisional)
Masanobu Kimura (Takara Bio)

[Reference] Last year’s JHVS 2019 news article

Please see the following for our exhibition report article.
https://braizon.com/en-news/20191125-2/

BACK